Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

DESOWEN CREAM 0.05% [SIN08252P]

Active ingredients: DESOWEN CREAM 0.05%

View product's general information
Last updated 24 April 2026

Product Info

DESOWEN CREAM 0.05%

[SIN08252P]

Product information

Active Ingredient and Strength

DESONIDE - 0.05%

Dosage Form

CREAM

Manufacturer and Country

LABORATOIRES GALDERMA - FRANCE

Registration Number

SIN08252P

Licence Holder

GALDERMA SINGAPORE PRIVATE LIMITED

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

D07AB08

Prescription-only Medicines with Exemptions for Supply without Prescription

As a topical cream or lotion preparation containing not more than 0.05% w/w

  • Indication: Treatment of redness, swelling and itching that is associated with minor skin ailments such as eczema.

  • Maximum daily dose: 2 to 3 times daily depending on severity.

  • Maximum supply: 15 g (cream) or 60 ml (lotion)

  • Minimum age: 18 years

Indication

Indication:
Desonide (Desowen) Cream 0.05% and Lotion 0.05% are indicated for the relief of the inflammatory and pruritic manifestation of corticosteroid-responsive dermatoses.

Dosing

Dosage and Administration:
Desonide (Desowen) Cream 0.05% or Lotion 0.05% should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions or as prescribed by a physician. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Contraindications

Contraindication:
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any components of the preparations.